Site icon pharmaceutical daily

Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting

Newly Launched Q Guidance System with Spine Guidance Software Receives 2022 Spine Technology Award

KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK), one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society (NASS) annual meeting in Chicago, Oct. 12–15 (booth #4211).

“Our expanding portfolio of differentiated spinal procedural innovations demonstrates our commitment to bringing state-of-the-art technology to surgeons and their patients,” said Robbie Robinson, President of the Spine division, Stryker. “This has been an exciting year with several new products launched, signifying the continued growth of our Spine business. We are thrilled to reconnect with current and make the acquaintance of future customers as well as showcase our newest additions at NASS.”

The Company will highlight legacy solutions along with several newly launched products, which include:

Stryker will showcase its portfolio of spine solutions at NASS (booth #4211), including a chance to experience the technologies hands-on during a Surgical Stadium event taking place Friday, October 14, from 10:45 a.m.–12:00 p.m. in the Technical Exhibition McCormick Place, West Building, with proctors Drs. Shah Dodwad and Griffin R. Baum.

*Cranial Guidance Software has not yet received 510(k) clearance to market.

**Mako for spine applications is not available for sale.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, and Orthopaedics and Spine that help improve patient and hospital outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.

References:

1. Stryker data on file; RD 62430 Tritanium hMSC osteogenic differentiation.

2. Reza, A. et al. “Randomized porous titanium impacts cell morphology and induces stem cell differentiation in vitro.” Orthopaedic Research Society 5th International Spine Research Symposium, 2019, 5: 83.

3. Stryker data on file (10-minute Bone Mill+ cycle vs 10 minutes of manual soft tissue removal)

4. Stryker data on file (Based on fill volume)

CONTENT ID: QGS-MM-2_3426

Contacts

Andrea Sampson, Sampson Public Relations Group

562.304.0301

asampson@sampsonprgroup.com

Exit mobile version